Picture of Bioxyne logo

BXN Bioxyne Balance Sheet

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapFalling Star

Annual balance sheet for Bioxyne, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

C2017
June 30th
C2018
June 30th
2019
June 30th
2020
June 30th
2021
June 30th
Period Length:
Source:Interim ReportARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments3.883.311.771.751.6
Net Total Accounts Receivable
Net Total Receivables0.5370.6840.7790.3180.364
Total Inventory
Total Other Current Assets
Total Current Assets4.514.733.523.072.51
Net Property, Plant And Equipment0.0030.1610.2090.2350.138
Net Intangible Assets
Total Assets4.745.053.973.342.68
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.610.7290.8290.7260.745
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities0.610.7290.8820.7790.798
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity4.134.323.092.561.88
Total Liabilities & Shareholders' Equity4.745.053.973.342.68
Total Common Shares Outstanding

Or unlock with your email

Or unlock with your email